查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404789

全球给药装置市场：规模、份额和趋势分析报告 - 按应用、给药途径、最终用途、地区、细分市场预测，2024-2030 年

Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application (Oncology, Infectious Diseases), By Route Of Administration (Oral, Transdermal, Injectable), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10个工作天内

价格

给药装置市场成长与趋势：

预计2030年，全球给药装置市场规模将达4,036亿美元，预测期内复合年增长率为5.83%。

癌症、神经系统疾病、糖尿病和其他感染疾病的日益普及预计将在未来几年推动药物输送设备的采用。增加眼科、神经病学和肿瘤学等各种应用的产品推出也有望推动市场成长。居家医疗环境中越来越多地采用穿戴式药物输送设备也有望推动市场发展。

水凝胶是重要的药物传递载体之一，包括超分子水凝胶、DNA水凝胶、仿生水凝胶、多功能水凝胶、刺激反应水凝胶等。这些先进的水凝胶可用于多种应用，包括眼科、口腔、肠道、心臟疾病和癌症应用。同样，脂质体、奈米粒子和胶束等其他载体也正在开发用于各种应用。

市场上的主要公司正在采取各种策略，例如併购、联盟和联合研究，来开发和改进各种应用的药物传输装置。此外，最终用户还与公司合作以获得用于培训和研究目的的药物传输设备。此外，市场参与者正在签订分销商协议，以扩大其产品的覆盖范围。因此，预计每家公司的联盟将在预测期内推动市场成长。

药物输送设备市场报告亮点：

  • 口服给药途径细分市场在 2023 年占据最大份额，主要是因为其易于使用且成本低。
  • 在预测期内，注射给药途径预计将出现最快的增长，这主要是由于注射给药设备的不断进步以提高准确性。
  • 用于中枢神经系统疾病的药物输送装置预计将在预测期内快速增长，这主要是由于用于治疗神经系统疾病的血脑障壁药物输送装置的开发取得了进展。
  • 2023年，由于该地区药物输送设备的采用增加以及美国等国家产品的推出，北美地区占据了全球最大的收益占有率。
  • 由于药物输送设备的高度发展和进步以及庞大的患者群体，预计亚太地区在预测期内将出现最快的成长率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章给药装置市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和增长的前景图
  • 产业价值链分析
    • 赎回框架
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
    • 产业挑战
  • 给药装置市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略联盟分析
    • 打入市场策略

第4章给药途径（RoA）的估算与趋势分析

  • 定义和范围
    • 口服
    • 吸入
    • 经皮的
    • 注射
    • 眼睛
    • 鼻腔
    • 局部的
    • 其他的
  • 投资报酬率市场占有率，2024/2030
  • 细分仪表板
  • 全球给药装置市场：RoA 展望
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 口服
    • 吸入
    • 经皮的
    • 注射
    • 眼睛
    • 鼻腔
    • 局部的
    • 其他的

第五章 使用估算/趋势分析

  • 定义和范围
    • 肿瘤学
    • 感染疾病
    • 呼吸系统疾病
    • 糖尿病
    • 循环系统疾病
    • 自体免疫疾病
    • 中枢神经系统疾病
    • 其他的
  • 应用市场占有率，2024/2030
  • 细分仪表板
  • 全球给药装置市场：按应用分類的前景
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 肿瘤学
    • 感染疾病
    • 呼吸系统疾病
    • 糖尿病
    • 心血管疾病
    • 自体免疫疾病
    • 中枢神经系统疾病
    • 其他的

第六章 最终用途估算及趋势分析

  • 定义和范围
    • 医院
    • 诊断中心
    • 门诊手术中心/诊所
    • 居家照护设置
    • 其他的
  • 最终用途市场占有率，2023/2030
  • 细分仪表板
  • 全球给药装置市场：依最终用途分類的前景
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 医院
    • 诊断中心
    • 门诊手术中心/诊所
    • 居家照护设置
    • 其他的

第七章给药装置市场：区域估计与趋势分析

  • 2023/2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2019年区域市场占有率和主要企业
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲
  • 依因素（政治/法律、经济/技术）进行 SWOT 分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲
  • 市场规模/预测、数量/趋势分析，2018-2030
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • 创新者
    • 市场贷款人
    • 新兴企业
  • 供应商形势
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
  • 上市公司
  • 民营企业
  • 供应商排名
  • 主要企业简介
    • Pfizer, Inc,
    • F. Hoffmann-La Roche Ltd.
    • Johnson and Johnson Services
    • Novartis AG
    • Bayer AG
    • BD
    • Uniqure NV
    • SiBiono GeneTech Co.
    • Shanghai Sunway Biotech Co., Ltd
    • Human Stem Cells Institute
Product Code: GVR-4-68038-435-2

Drug Delivery Devices Market Growth & Trends:

The global drug delivery devices market size is expected to reach USD 403.6 billion by 2030, registering a CAGR of 5.83% during the forecast period, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.

Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.

Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.

Drug Delivery Devices Market Report Highlights:

  • The oral route of administration segment held largest share in 2023 mainly due to its easy usage and low cost
  • The injectable route of administration segment is expected to experience the fastest growth during the forecast period mainly due to growing advancements in injectable devices for accuracy
  • Drug delivery devices for central nervous system disorders are expected to experience fastest growth rate mainly due to growing development of blood brain barrier drug delivery devices for the treatment of neurological disorders
  • In 2023, North America dominated the global space with the largest revenue share owing to the adoption of drug delivery devices in the region and increasing product launches in the countries such as U.S.
  • Asia Pacific is expected to grow at fastest growth rate during the forecast period mainly due to growing development and advancement in drug delivery devices in the region and presence of large patient pool.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Route of admission (RoA)
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interview in North America
      • 1.3.5.2. Data for primary interview in Europe
      • 1.3.5.3. Data for primary interview in Asia Pacific
      • 1.3.5.4. Data for primary interview in Latin America
      • 1.3.5.5. Data for primary interview in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Route of administration (RoA) outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Growing demand for novel drug delivery devices
      • 3.4.1.2. Increasing prevalence of chronic diseases
      • 3.4.1.3. Technological advancement in drug delivery devices
      • 3.4.1.4. Growing strategic alliances for drug delivery devices
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Challenges associated with various routes of drug delivery devices
    • 3.4.3. Industry challenges
  • 3.5. Drug Delivery Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Route of Administration (RoA) Estimates & Trend Analysis

  • 4.1. Definition and Scope
    • 4.1.1. Oral
    • 4.1.2. Inhalation
    • 4.1.3. Transdermal
    • 4.1.4. Injectable
    • 4.1.5. Ocular
    • 4.1.6. Nasal
    • 4.1.7. Topical
    • 4.1.8. Others
  • 4.2. RoA Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Drug Delivery Devices Market by RoA Outlook
  • 4.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
    • 4.5.1. Oral
      • 4.5.1.1. Market estimates and forecast, by oral, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.2. Inhalation
      • 4.5.2.1. Market estimates and forecast, by inhalation, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.3. Transdermal
      • 4.5.3.1. Market estimates and forecast, by transdermal, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.4. Injectable
      • 4.5.4.1. Market estimates and forecast, by injectable, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.5. Ocular
      • 4.5.5.1. Market estimates and forecast, by ocular, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.6. Nasal
      • 4.5.6.1. Market estimates and forecast, by nasal, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.7. Topical
      • 4.5.7.1. Market estimates and forecast, by tropical, 2018 to 2030 (Revenue, USD Billion)
    • 4.5.8. Others
      • 4.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 5. Application Estimates & Trend Analysis

  • 5.1. Definition and Scope
    • 5.1.1. Oncology
    • 5.1.2. Infectious diseases
    • 5.1.3. Respiratory disease
    • 5.1.4. Diabetes
    • 5.1.5. Cardiovascular disease
    • 5.1.6. Autoimmune disease
    • 5.1.7. Central nervous system disorders
    • 5.1.8. Others
  • 5.2. Application Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Drug Delivery Devices Market by Application Outlook
  • 5.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
    • 5.5.1. Oncology
      • 5.5.1.1. Market estimates and forecast, by oncology, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.2. Infectious disease
      • 5.5.2.1. Market estimates and forecast, by infectious disease, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.3. Respiratory disease
      • 5.5.3.1. Market estimates and forecast, by respiratory disease, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.4. Diabetes
      • 5.5.4.1. Market estimates and forecast, by diabetes, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.5. Cardiovascular diseases
      • 5.5.5.1. Market estimates and forecast, by cardiovascular diseases, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.6. Autoimmune disease
      • 5.5.6.1. Market estimates and forecast, by autoimmune disease, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.7. Central nervous system disorders
      • 5.5.7.1. Market estimates and forecast, by central nervous system disorders, 2018 to 2030 (Revenue, USD Billion)
    • 5.5.8. Others
      • 5.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 6. End-use Estimates & Trend Analysis

  • 6.1. Definition and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Diagnostic centers
    • 6.1.3. Ambulatory surgery centers/clinics
    • 6.1.4. Home care settings
    • 6.1.5. Others
  • 6.2. End-use Market Share, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Drug Delivery Devices Market by End-use Outlook
  • 6.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
    • 6.5.1. Hospital
      • 6.5.1.1. Market estimates and forecast, by hospital, 2018 to 2030 (Revenue, USD Billion)
    • 6.5.2. Diagnostic centers
      • 6.5.2.1. Market estimates and forecast, by diagnostic centers, 2018 to 2030 (Revenue, USD Billion)
    • 6.5.3. Ambulatory surgery centers/clinics
      • 6.5.3.1. Market estimates and forecast, by ambulatory surgery centers/clinics, 2018 to 2030 (Revenue, USD Billion)
    • 6.5.4. Home care settings
      • 6.5.4.1. Market estimates and forecast, by home care settings, 2018 to 2030 (Revenue, USD Billion)
    • 6.5.5. Others
      • 6.5.5.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2019
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East & Africa
  • 7.5. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East & Africa
  • 7.6. Market Size & Forecast, Volume & Trend Analysis, 2018 to 2030
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.2. U.S.
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.3. Canada
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8. Europe
    • 7.8.1. UK
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.2. Germany
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.3. France
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement structure
      • 7.8.3.5. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.4. Italy
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Reimbursement structure
      • 7.8.4.5. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.5. Spain
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Reimbursement structure
      • 7.8.5.5. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.6. Denmark
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Competitive scenario
      • 7.8.6.3. Regulatory framework
      • 7.8.6.4. Reimbursement structure
      • 7.8.6.5. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.7. Sweden
      • 7.8.7.1. Key country dynamics
      • 7.8.7.2. Competitive scenario
      • 7.8.7.3. Regulatory framework
      • 7.8.7.4. Reimbursement structure
      • 7.8.7.5. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.8. Norway
      • 7.8.8.1. Key country dynamics
      • 7.8.8.2. Competitive scenario
      • 7.8.8.3. Regulatory framework
      • 7.8.8.4. Reimbursement structure
      • 7.8.8.5. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9. Asia Pacific
    • 7.9.1. Japan
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.2. China
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.3. India
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.4. Australia
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.5. South Korea
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Competitive scenario
      • 7.9.5.3. Regulatory framework
      • 7.9.5.4. Reimbursement structure
      • 7.9.5.5. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.6. Thailand
      • 7.9.6.1. Key country dynamics
      • 7.9.6.2. Competitive scenario
      • 7.9.6.3. Regulatory framework
      • 7.9.6.4. Reimbursement structure
      • 7.9.6.5. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.10. Latin America
    • 7.10.1. Brazil
      • 7.10.1.1. Key country dynamics
      • 7.10.1.2. Competitive scenario
      • 7.10.1.3. Regulatory framework
      • 7.10.1.4. Reimbursement structure
      • 7.10.1.5. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.10.2. Mexico
      • 7.10.2.1. Key country dynamics
      • 7.10.2.2. Competitive scenario
      • 7.10.2.3. Regulatory framework
      • 7.10.2.4. Reimbursement structure
      • 7.10.2.5. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.10.3. Argentina
      • 7.10.3.1. Key country dynamics
      • 7.10.3.2. Competitive scenario
      • 7.10.3.3. Regulatory framework
      • 7.10.3.4. Reimbursement structure
      • 7.10.3.5. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.11. MEA
    • 7.11.1. South Africa
      • 7.11.1.1. Key country dynamics
      • 7.11.1.2. Competitive scenario
      • 7.11.1.3. Regulatory framework
      • 7.11.1.4. Reimbursement structure
      • 7.11.1.5. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Key country dynamics
      • 7.11.2.2. Competitive scenario
      • 7.11.2.3. Regulatory framework
      • 7.11.2.4. Reimbursement structure
      • 7.11.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.11.3. UAE
      • 7.11.3.1. Key country dynamics
      • 7.11.3.2. Competitive scenario
      • 7.11.3.3. Regulatory framework
      • 7.11.3.4. Reimbursement structure
      • 7.11.3.5. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 7.11.4. Kuwait
      • 7.11.4.1. Key country dynamics
      • 7.11.4.2. Competitive scenario
      • 7.11.4.3. Regulatory framework
      • 7.11.4.4. Reimbursement structure
      • 7.11.4.5. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
    • 8.2.2. Market Lenders
    • 8.2.3. Emerging Players
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
  • 8.4. Public Companies
    • 8.4.1. Company market position analysis (Revenue, geographic, presence, product portfolio, key serviceable industries, key alliance
    • 8.4.2. Company market share/ranking, by region
    • 8.4.3. Competitive dashboard analysis
      • 8.4.3.1. Market differentiators
      • 8.4.3.2. Synergy analysis: major deals and strategic alliances
  • 8.5. Private Companies
    • 8.5.1. List of key emerging companies/technology disruptors/innovators
    • 8.5.2. Funding outlook
    • 8.5.3. Regional network map
    • 8.5.4. Company market position analysis (Geographic, presence, product portfolio, key alliance, industry experience)
  • 8.6. Suppliers Ranking
  • 8.7. Key Companies Profiled
    • 8.7.1. Pfizer, Inc,
      • 8.7.1.1. Company overview
      • 8.7.1.2. Financial performance
      • 8.7.1.3. Product benchmarking
      • 8.7.1.4. Strategic initiatives
    • 8.7.2. F. Hoffmann-La Roche Ltd.
      • 8.7.2.1. Company overview
      • 8.7.2.2. Financial performance
      • 8.7.2.3. Product benchmarking
      • 8.7.2.4. Strategic initiatives
    • 8.7.3. Johnson and Johnson Services
      • 8.7.3.1. Company overview
      • 8.7.3.2. Financial performance
      • 8.7.3.3. Product benchmarking
      • 8.7.3.4. Strategic initiatives
    • 8.7.4. Novartis AG
      • 8.7.4.1. Company overview
      • 8.7.4.2. Financial performance
      • 8.7.4.3. Product benchmarking
      • 8.7.4.4. Strategic initiatives
    • 8.7.5. Bayer AG
      • 8.7.5.1. Company overview
      • 8.7.5.2. Financial performance
      • 8.7.5.3. Product benchmarking
      • 8.7.5.4. Strategic initiatives
    • 8.7.6. BD
      • 8.7.6.1. Company overview
      • 8.7.6.2. Financial performance
      • 8.7.6.3. Product benchmarking
      • 8.7.6.4. Strategic initiatives
    • 8.7.7. Uniqure N.V.
      • 8.7.7.1. Company overview
      • 8.7.7.2. Financial performance
      • 8.7.7.3. Product benchmarking
      • 8.7.7.4. Strategic initiatives
    • 8.7.8. SiBiono GeneTech Co.
      • 8.7.8.1. Company overview
      • 8.7.8.2. Financial performance
      • 8.7.8.3. Product benchmarking
      • 8.7.8.4. Strategic initiatives
    • 8.7.9. Shanghai Sunway Biotech Co., Ltd
      • 8.7.9.1. Company overview
      • 8.7.9.2. Financial performance
      • 8.7.9.3. Product benchmarking
      • 8.7.9.4. Strategic initiatives
    • 8.7.10. Human Stem Cells Institute
      • 8.7.10.1. Company overview
      • 8.7.10.2. Financial performance
      • 8.7.10.3. Product benchmarking
      • 8.7.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America drug delivery devices market, by country, 2018 - 2030 (USD Billion)
  • Table 3 North America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 4 North America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 5 North America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 6 U.S. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 7 U.S. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 8 U.S. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 Canada drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 10 Canada drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 11 Canada drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 12 Europe drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 13 Europe drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 14 Europe drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 15 Europe drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 Germany drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 17 Germany drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 18 Germany drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 19 U.K. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 20 U.K. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 21 U.K. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 22 France drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 23 France drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 24 France drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 25 Italy drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 26 Italy drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 27 Italy drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 28 Spain drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 29 Spain drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 30 Spain drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 31 Denmark drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 32 Denmark drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 33 Denmark drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 34 Sweden drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 35 Sweden drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 36 Sweden drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 Norway drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 38 Norway drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 39 Norway drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 40 APAC drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 41 APAC drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 42 APAC drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 43 APAC drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 44 China drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 45 China drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 46 China drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 47 Japan drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 48 Japan drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 49 Japan drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 50 India drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 51 India drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 52 India drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 53 Thailand drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 54 Thailand drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 55 Thailand drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 56 South Korea drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 57 South Korea drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 58 South Korea drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 59 Australia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 60 Australia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 61 Australia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 62 Latin America drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 63 Latin America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 64 Latin America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Latin America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 66 Brazil drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 67 Brazil drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 68 Brazil drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 69 Mexico drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 70 Mexico drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 71 Mexico drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 72 Argentina drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 73 Argentina drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 74 Argentina drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 75 Middle East and Africa drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 76 Middle East and Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 77 Middle East and Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 78 Middle East and Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 79 South Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 80 South Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 81 South Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 82 Saudi Arabia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 83 Saudi Arabia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 84 Saudi Arabia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 85 UAE drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 86 UAE drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 87 UAE drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 88 Kuwait drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
  • Table 89 Kuwait drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 90 Kuwait drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Drug delivery devices: market outlook
  • Fig. 14 Drug delivery devices market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook.
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Drug delivery devices market driver impact
  • Fig. 20 Drug delivery devices market restraint impact
  • Fig. 21 Drug delivery devices market strategic initiatives analysis
  • Fig. 22 Drug delivery devices market: RoA movement analysis
  • Fig. 23 Drug delivery devices market: RoA outlook and key takeaways
  • Fig. 24 Oral market estimates and forecast, 2018 - 2030
  • Fig. 25 Inhalation market estimates and forecast, 2018 - 2030
  • Fig. 26 Transdermal market estimates and forecast, 2018 - 2030
  • Fig. 27 Injectable market estimates and forecast, 2018 - 2030
  • Fig. 28 Ocular market estimates and forecast, 2018 - 2030
  • Fig. 29 Nasal market estimates and forecast, 2018 - 2030
  • Fig. 30 Topical market estimates and forecast, 2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Drug delivery devices market: application movement analysis
  • Fig. 33 Drug delivery devices market: application outlook and key takeaways
  • Fig. 34 Oncology market estimates and forecast, 2018 - 2030
  • Fig. 35 Infectious diseases estimates and forecast, 2018 - 2030
  • Fig. 36 Respiratory diseases estimates and forecast, 2018 - 2030
  • Fig. 37 Diabetes estimates and forecast, 2018 - 2030
  • Fig. 38 Cardiovascular diseases estimates and forecast, 2018 - 2030
  • Fig. 39 Autoimmune diseases estimates and forecast, 2018 - 2030
  • Fig. 40 Central nervous system disorders estimates and forecast, 2018 - 2030
  • Fig. 41 Others estimates and forecast, 2018 - 2030
  • Fig. 42 Drug delivery devices market: end-use movement analysis
  • Fig. 43 Drug delivery devices market: End-use outlook and key takeaways
  • Fig. 44 Hospitals estimates and forecast, 2018 - 2030
  • Fig. 45 Diagnostic centers estimates and forecast, 2018 - 2030
  • Fig. 46 Ambulatory surgery centers/clinics estimates and forecast, 2018 - 2030
  • Fig. 47 Home care setting estimates and forecast, 2018 - 2030
  • Fig. 48 Others estimates and forecast, 2018 - 2030
  • Fig. 49 Global drug delivery devices market: regional movement analysis
  • Fig. 50 Global drug delivery market: regional outlook and key takeaways
  • Fig. 51 Global market share and leading players
  • Fig. 52 North America market share and leading players
  • Fig. 53 Europe market share and leading players
  • Fig. 54 Asia Pacific market share and leading players
  • Fig. 55 Latin America market share and leading players
  • Fig. 56 Middle East & Africa market share and leading players
  • Fig. 57 North America: SWOT
  • Fig. 58 Europe SWOT
  • Fig. 59 Asia Pacific SWOT
  • Fig. 60 Latin America SWOT
  • Fig. 61 MEA SWOT
  • Fig. 62 North America, by country
  • Fig. 63 North America
  • Fig. 64 North America market estimates and forecast, 2018 - 2030
  • Fig. 65 U.S.
  • Fig. 66 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 67 Canada
  • Fig. 68 Canada market estimates and forecast, 2018 - 2030
  • Fig. 69 Europe
  • Fig. 70 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 71 UK
  • Fig. 72 UK market estimates and forecast, 2018 - 2030
  • Fig. 73 Germany
  • Fig. 74 Germany market estimates and forecast, 2018 - 2030
  • Fig. 75 France
  • Fig. 76 France market estimates and forecast, 2018 - 2030
  • Fig. 77 Italy
  • Fig. 78 Italy market estimates and forecast, 2018 - 2030
  • Fig. 79 Spain
  • Fig. 80 Spain market estimates and forecast, 2018 - 2030
  • Fig. 81 Denmark
  • Fig. 82 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 83 Sweden
  • Fig. 84 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 85 Norway
  • Fig. 86 Norway market estimates and forecast, 2018 - 2030
  • Fig. 87 Asia Pacific
  • Fig. 88 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 89 China
  • Fig. 90 China market estimates and forecast, 2018 - 2030
  • Fig. 91 Japan
  • Fig. 92 Japan market estimates and forecast, 2018 - 2030
  • Fig. 93 India
  • Fig. 94 India market estimates and forecast, 2018 - 2030
  • Fig. 95 Thailand
  • Fig. 96 Thailand. market estimates and forecast, 2018 - 2030
  • Fig. 97 South Korea
  • Fig. 98 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 99 Australia
  • Fig. 100 Australia market estimates and forecast, 2018 - 2030
  • Fig. 101 Latin America
  • Fig. 102 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 103 Brazil
  • Fig. 104 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 105 Mexico
  • Fig. 106 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 107 Argentina
  • Fig. 108 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 109 Middle East and Africa
  • Fig. 110 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 111 South Africa
  • Fig. 112 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 113 Saudi Arabia
  • Fig. 114 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 115 UAE
  • Fig. 116 UAE market estimates and forecast, 2018 - 2030
  • Fig. 117 Kuwait
  • Fig. 118 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 119 Participant categorization- drug delivery devices market
  • Fig. 120 Market share of key market players- drug delivery devices market